Literature DB >> 16464408

Treatment options for autonomic neuropathies.

Christopher H Gibbons1, Roy Freeman.   

Abstract

Autonomic disorders may present in a varied fashion. Symptoms that may require treatment include orthostatic intolerance, gastrointestinal distress, sudomotor abnormalities, and urologic and sexual dysfunction. Realistic treatment goals should be outlined for patients, with the expectations that symptoms can be improved, but that the disease is unlikely to be cured and long-term therapy may be required. Orthostatic intolerance is usually treated by a combination of pharmacologic and nonpharmacologic therapies. Nonpharmacologic therapies include compression stockings, adequate fluid and salt intake, and lifestyle modifications. Polypharmacologic therapy is often the standard and can include a volume-expanding agent (such as fludrocortisone) and a sympathomimetic agent. This combination will improve symptoms dramatically in most patients. Treatment of gastrointestinal disorders should address the particular symptom involved: gastroparesis, constipation, or diarrhea. Treatment of sexual and urogenital dysfunction often requires a combination of pharmacologic intervention and lifestyle modifications for peak effectiveness. Patient education is the cornerstone of treatment in any of the autonomic disorders. Given enough education and motivation, many patients will be able to participate in their treatment, which will provide a feeling of empowerment and control over a disease that is often frustratingly resistant to treatment.

Entities:  

Year:  2006        PMID: 16464408     DOI: 10.1007/s11940-006-0003-0

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.972


  43 in total

1.  High-frequency gastric stimulation in a patient with diabetic gastroparesis.

Authors:  D J Patterson; R C Thirlby; M A Sobrino
Journal:  Diabet Med       Date:  2004-02       Impact factor: 4.359

2.  Clinical improvement in patients with orthostatic intolerance after treatment with bisoprolol and fludrocortisone.

Authors:  J Freitas; R Santos; E Azevedo; O Costa; M Carvalho; A F de Freitas
Journal:  Clin Auton Res       Date:  2000-10       Impact factor: 4.435

3.  Suprachiasmatic nucleus in a patient with multiple system atrophy with abnormal circadian rhythm of arginine-vasopressin secretion into plasma.

Authors:  T Ozawa; K Oyanagi; H Tanaka; Y Horikawa; H Takahashi; T Morita; S Tsuji
Journal:  J Neurol Sci       Date:  1998-01-21       Impact factor: 3.181

4.  Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson's disease or multiple system atrophy with observations on orthostatic hypotension.

Authors:  I F Hussain; C M Brady; M J Swinn; C J Mathias; C J Fowler
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-09       Impact factor: 10.154

5.  A new minimally invasive procedure for pudendal nerve stimulation to treat neurogenic bladder: description of the method and preliminary data.

Authors:  Michele Spinelli; Silvia Malaguti; Gianluca Giardiello; Massimo Lazzeri; Jessica Tarantola; Ubi Van Den Hombergh
Journal:  Neurourol Urodyn       Date:  2005       Impact factor: 2.696

6.  Water drinking as a treatment for orthostatic syndromes.

Authors:  John R Shannon; Andre Diedrich; Italo Biaggioni; Jens Tank; Rose Marie Robertson; David Robertson; Jens Jordan
Journal:  Am J Med       Date:  2002-04-01       Impact factor: 4.965

Review 7.  A systematic review of surgical therapy for gastroparesis.

Authors:  Michael P Jones; Kalyani Maganti
Journal:  Am J Gastroenterol       Date:  2003-10       Impact factor: 10.864

8.  Treatment of orthostatic hypotension with erythropoietin.

Authors:  R D Hoeldtke; D H Streeten
Journal:  N Engl J Med       Date:  1993-08-26       Impact factor: 91.245

9.  Management of spinal cord injured patients by indwelling suprapubic catheterization.

Authors:  S A MacDiarmid; E P Arnold; N B Palmer; A Anthony
Journal:  J Urol       Date:  1995-08       Impact factor: 7.450

10.  A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension.

Authors:  R A Wright; H C Kaufmann; R Perera; T L Opfer-Gehrking; M A McElligott; K N Sheng; P A Low
Journal:  Neurology       Date:  1998-07       Impact factor: 9.910

View more
  3 in total

1.  Endovascular procedures for the treatment of autonomic dysfunction.

Authors:  Christopher Gibbons; William Cheshire; Alexandru Barboi; Benjamin Levine; Brian Olshansky; Laurence Kinsella; Victoria E Claydon; Craig Crandall; Gregory Fink; Michael Joyner; Vaughan Macefield; Lucy Norcliffe-Kaufmann; Roy Freeman; Satish Raj; Julian Stewart; Paola Sandroni; Horacio Kaufmann; Thomas Chelimsky
Journal:  Clin Auton Res       Date:  2013-11-01       Impact factor: 4.435

2.  Autonomic mechanisms and therapeutic implications of postural diabetic cardiovascular abnormalities.

Authors:  Rohit R Arora; Robert J Bulgarelli; Samanwoy Ghosh-Dastidar; Joseph Colombo
Journal:  J Diabetes Sci Technol       Date:  2008-07

3.  Lower urinary tract dysfunction in patients with dysautonomia.

Authors:  Melissa St Aubin; Anand Shridharani; Alexandru C Barboi; Michael L Guralnick; Safwan S Jaradeh; Thomas E Prieto; R Corey O'Connor
Journal:  Clin Auton Res       Date:  2015-11-03       Impact factor: 4.435

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.